Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients
International Journal of Clinical & Laboratory Research · 1992
DOI: 10.1007/bf02591393 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical & Laboratory Research, 1992. Verfasst von L Isa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicine, Gorgonzola-Melzo Hospital, Milan, Italy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
We investigated the zinc concentration in blood and the effect of zinc supplementation in 11 male outpatients seropositive for human immunodeficiency virus at stage 5 according to the Walter Reed classification. Zinc concentration was measured in serum, platelets, mononuclear and polymorphonuclear cells, and erythrocytes. There was a significant increase in serum zinc concentration after zinc administration, but the zinc level in blood cells remained unchanged. All patients showed a progressive gain in body weight and a slight elevation in levels of CD4+ cells. No adverse side-effects were noticed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Medicine, Gorgonzola-Melzo Hospital, Milan, Italy.
Zitieren
APA
Isa, L., Lucchini, A., Lodi, S., & Giachetti, M. (1992). Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients. International Journal of Clinical & Laboratory Research. https://doi.org/10.1007/bf02591393
Vancouver
Isa L, Lucchini A, Lodi S, Giachetti M. Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients. International Journal of Clinical & Laboratory Research. 1992. doi:10.1007/bf02591393
BibTeX
@article{Isa1992,
author = {Isa, L and Lucchini, A and Lodi, S and Giachetti, M},
title = {Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients},
journal = {International Journal of Clinical & Laboratory Research},
year = {1992},
doi = {10.1007/bf02591393}
}
EUVIMED